[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
Powered by Google

FDA Public Health Advisory
Consumers Should Not Use Triaminic Vapor Patch

This product is not currently available for purchase in the U.S.

The U.S. Food and Drug Administration (FDA) is warning consumers not to use Triaminic Vapor Patch. Triaminic Vapor Patch may cause serious harm if children accidentally take it in by mouth.

Triaminic Vapor Patch is advertised as a cough suppressant for children two years of age and older and is available in two scents, mentholated cherry scent and menthol scent. The patch contains camphor, eucalyptus oil and menthol. The directions on the label say that the patch is to be applied to the throat or chest to allow the vapors to reach the nose and mouth. Once applied, the patch would be within close reach for a child to remove and put in their mouth. In addition, the cherry scent could entice a child to chew or swallow the patch. Swallowing products containing camphor or eucalyptus oils can cause minor symptoms, such as a burning sensation in the mouth, headache, nausea and vomiting, and more severe and life-threatening events, such as seizures.

FDA is aware of one harmful event reported in Canada associated with the use of the identical version of the Triaminic Vapor Patch; a two year old child, reported to have had a seizure after chewing on a Triaminic Vapor Patch.

The manufacturer of Triaminic Vapor Patch, Novartis Consumer Health, is voluntarily recalling Triaminic Vapor Patch. Unused Triaminic Vapor Patches should be returned to the place where they were purchased or discarded it in the trash. Consumers requiring more information about this recall can contact Novartis Consumer and Professional Affairs Call Center at 1-800-452-0051.

Any adverse reactions experienced with the use of this product, and/or quality problems should be reported to the FDA's MedWatch Adverse Event Reporting program online at www.fda.gov/MedWatch/report.htm, by phone [1-800-FDA-1088], or by returning the postage-paid FDA form 3500, which may be downloaded from www.fda.gov/MedWatch/getforms.htm, by mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 or fax [1-800-FDA-0178].

FDA News: FDA Warns Consumers Not to Use Triaminic Vapor Patch: Possible safety and health risks to children.

Back to Top     Back to Public Health Advisories

Date created: June 20, 2006, updated July 19, 2007